Progression of atropine 0.01% treatment group.

NIAID Data Ecosystem40

Additional file 1 of Efficacy and safety of atropine to control myopia progression: a systematic review and meta-analysis

近视药物干预

循证医学

Additional file 1.

Figshare2020-12-08 更新30

Baseline characteristics of all included studies.

近视控制治疗

阿托品疗效评估

Objective To evaluate the efficacy and safety of 0.01% atropine alone and in combination with orthokeratology for myopia control using a meta-analysis. Methods PubMed, Cochrane Library, and EMBASE wer

NIAID Data Ecosystem20

Additional file 1 of Efficacy and safety of atropine to control myopia progression: a systematic review and meta-analysis

资源简介：

相关数据集